Fermelanta, Inc.
Applied Research on Microbial Fermentative Production of Valuable Compounds through Multi-Step Metabolic Pathways

As of October, 2025
| City | Year of Establishment | Founder |
|---|---|---|
| Nonoichi, Ishikawa | 2022 | Shogo Fukizaki Hiromichi Minami Akira Nakagawa |
| Partner VC | Latest round of Fundraising | Valuation |
|---|---|---|
| Beyond Next Ventures Inc. | Series A | JYP 8,000 million |
- Contact Information: info@fermelanta.com
- Website: Fermelanta, Inc.
Program name
Deep-Tech Startups Support Program
Research theme
Applied Research on Microbial Fermentative Production of Valuable Compounds through Multi-Step Metabolic Pathways
Business Plan
Natural compounds with complex chemical structures often contain components beneficial to human health; however, their total chemical synthesis is difficult, and no efficient or cost-effective method for large-scale production currently exists.
By overcoming the technical challenges of introducing multiple heterologous genes into microorganisms, functionally expressing enzymes, and systematically controlling them as an integrated biological system, this research aims to establish multi-step biosynthetic pathways based on continuous enzymatic reactions. Through this approach, we seek to develop foundational technologies for constructing industrial microbial strains capable of producing target compounds with high efficiency, and to realize their social implementation.
Research Outline
This research and development project aims to establish a fermentation technology using genetically engineered E. coli strains with newly introduced metabolic pathways, enabling the production of plant-derived compounds independent of climate and geographic conditions.
Furthermore, by achieving the following Proofs of Concept (PoC), the project seeks to solve key industrial challenges related to the stable supply and cost reduction of rare plant-derived compounds:
- Practical development of thebaine and cannabinoids
- Development of platform microbial strains with common metabolic pathways applicable to diverse intermediate compounds
- Construction of foundational technologies and general-purpose tools to support the development of customized microbial strains
| Phase | Business Area/Field | Research Period | Research Grant Amount |
|---|---|---|---|
| PCA | Materials | 2025-2027FY | JPY 499 million |
Last Updated : November 14, 2025